Scarica l'app Stockscreener
1.58
3.95%
0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Precedente Chiudi:
$1.52
Aprire:
$1.52
Volume 24 ore:
1.52M
Relative Volume:
1.36
Capitalizzazione di mercato:
$147.68M
Reddito:
$34.48M
Utile/perdita netta:
$-102.07M
Rapporto P/E:
-1.0822
EPS:
-1.46
Flusso di cassa netto:
$-104.90M
1 W Prestazione:
+0.64%
1M Prestazione:
-0.63%
6M Prestazione:
-18.97%
1 anno Prestazione:
+20.61%
Intervallo 1D:
$1.52
$1.64
Intervallo di 1 settimana:
$1.47
$1.65
Portata 52W:
$0.66
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
Nome
Caribou Biosciences Inc
Settore
Industria
Telefono
510-982-6030
Indirizzo
2929 7TH STREET, SUITE 105, BERKELEY
Compare CRBU vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.58 | 142.07M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Iniziato | Evercore ISI | Outperform |
| 2023-07-11 | Iniziato | Truist | Buy |
| 2022-02-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-08-17 | Iniziato | BofA Securities | Buy |
| 2021-08-17 | Iniziato | Citigroup | Neutral |
| 2021-08-17 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
Should you avoid Caribou Biosciences Inc. stock right nowInsider Selling & Long-Term Growth Plans - mfd.ru
Will Caribou Biosciences Inc. stock benefit from upcoming earnings reportsMarket Sentiment Summary & Weekly Return Optimization Plans - mfd.ru
Caribou Biosciences to Participate in Upcoming Investor Conferences - Investing News Network
Merger Talk: Is Caribou Biosciences Inc stock showing strong momentum2025 Trading Volume Trends & Verified Stock Trade Ideas - baoquankhu1.vn
CRISPR-focused Caribou set for fireside chats at 2 investor events - Stock Titan
What is Brookline Cap M's Forecast for CRBU FY2030 Earnings? - MarketBeat
Research Analysts Offer Predictions for CRBU FY2030 Earnings - MarketBeat
Bond Watch: How does Caribou Biosciences Inc compare to its peersLayoff News & AI Enhanced Trading Signals - baoquankhu1.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Caribou Biosciences (CRBU) and Boston Scientific (BSX) - The Globe and Mail
Caribou Biosciences (NASDAQ:CRBU) Shares Up 3.8%What's Next? - MarketBeat
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR - Investing News Network
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR® - The Manila Times
Off-the-shelf CAR-T data in lymphoma and myeloma head to 2026 Tandem - Stock Titan
Clear Street Initiates Caribou Biosciences(CRBU.US) With Buy Rating, Announces Target Price $13 - 富途牛牛
Caribou Biosciences a new buy at Clear Street on CAR-T pipeline - Seeking Alpha
Clear Street Initiates Coverage of Caribou Biosciences (CRBU) with Buy Recommendation - Nasdaq
Clear Street initiates coverage on Caribou Biosciences stock with Buy rating By Investing.com - Investing.com South Africa
Clear Street initiates coverage on Caribou Biosciences stock with Buy rating - Investing.com Nigeria
Guidance Update: Is PMTPRA a play on infrastructure spendingCEO Change & Intraday High Probability Setup Alerts - baoquankhu1.vn
Patterns Watch: How does Caribou Biosciences Inc compare to its peersEarnings Recap Report & Low Volatility Stock Recommendations - baoquankhu1.vn
Aug PreEarnings: Is Caribou Biosciences Inc a stock for growth or value investors2025 Risk Factors & Reliable Price Breakout Signals - baoquankhu1.vn
Trade Recap: Is Caribou Biosciences Inc stock good for income investorsJuly 2025 PreEarnings & Accurate Buy Signal Notifications - baoquankhu1.vn
Patterns Watch: Will ARAY benefit from rising consumer demandQuarterly Market Review & Weekly High Potential Alerts - baoquankhu1.vn
Take Profit: Is Caribou Biosciences Inc. stock good for income investorsJuly 2025 Gainers & Verified Chart Pattern Signals - baoquankhu1.vn
Caribou Biosciences Hits New 52-Week High at $3.54 - Markets Mojo
Trade Report: Can ULCC maintain its current growth rateTrade Analysis Report & Expert Curated Trade Setups - baoquankhu1.vn
Genome Editing Market Forecast to Reach $23.6 Billion by 2031 Registering 16.6% CAGR: Insights Into Technology and Investment Trends - GlobeNewswire Inc.
Sectors Review: Is Caribou Biosciences Inc a cyclical or defensive stockJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - baoquankhu1.vn
Recap Report: Is Caribou Biosciences Inc benefiting from interest rate changes2025 Biggest Moves & Community Verified Watchlist Alerts - baoquankhu1.vn
Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results - MSN
BofA Securities Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $6 - 富途牛牛
Caribou Biosciences (CRBU) Upgraded to Buy: Here's Why - sharewise.com
Caribou Biosciences (NASDAQ:CRBU) Shares Up 0.6%Should You Buy? - MarketBeat
Caribou Biosciences (CRBU) upgraded to buy: Here's why - MSN
Can Caribou Biosciences Inc. stock continue upward trendJuly 2025 PostEarnings & Risk Managed Trade Strategies - ulpravda.ru
What is the fair value of Caribou Biosciences Inc. stock now2025 Short Interest & Detailed Earnings Play Alerts - Улправда
How sustainable is Caribou Biosciences Inc. stock dividend payoutJuly 2025 Big Picture & Precise Buy Zone Identification - Улправда
Will Caribou Biosciences Inc. stock benefit from automation2025 Technical Patterns & Consistent Return Strategy Ideas - Улправда
Why Caribou Biosciences Inc. stock is rated strong buy2025 Market Sentiment & Growth Focused Stock Reports - Улправда
How Caribou Biosciences Inc. stock trades before earningsPortfolio Return Report & AI Based Trade Execution Alerts - Улправда
Can Caribou Biosciences Inc. stock sustain institutional interestMarket Sentiment Review & Low Drawdown Trading Techniques - Улправда
Can Caribou Biosciences Inc. stock sustain revenue growthM&A Rumor & Risk Adjusted Buy and Sell Alerts - Улправда
Income Plays: How analysts rate Caribou Biosciences Inc. stock todayMarket Risk Summary & High Conviction Buy Zone Picks - Улправда
Spotlight On Promising Penny Stocks In January 2026 - simplywall.st
Caribou Biosciences (CRBU) Gets a Buy from Bank of America Securities - The Globe and Mail
Aug Intraday: Can Caribou Biosciences Inc stock sustain revenue growthMarket Weekly Review & Daily Volume Surge Trade Alerts - moha.gov.vn
Caribou Biosciences (CRBU) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Caribou Biosciences Inc stock remain a Wall Street favoriteGold Moves & Low Risk Entry Point Guides - moha.gov.vn
What valuation multiples suggest for Caribou Biosciences Inc. stockGap Fill Strategies & Affordable Growth Investments - bollywoodhelpline.com
Caribou Biosciences Inc Azioni (CRBU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):